CD
AZN icon

Chapin Davis’s AstraZeneca AZN Stock Holding History

Chapin Davis’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$257K Sell
1,357
-477
-26% -$89.7K 0.05% 210
2026
Q1 		$362K Sell
1,834
-55
-3% -$10.6K 0.08% 184
2025
Q4 		$347K Sell
1,889
-9
-0.5% -$1.58K 0.08% 177
2025
Q3 		$291K Buy
1,898
+60
+3% +$9.08K 0.07% 196
2025
Q2 		$257K Sell
1,838
-99
-5% -$13.9K 0.07% 191
2025
Q1 		$285K Buy
1,937
+323
+20% +$46.7K 0.1% 168
2024
Q4 		$251K Hold
1,614
– – 0.08% 185
2024
Q3 		$251K Buy
1,614
+25
+2% +$4.04K 0.08% 186
2024
Q2 		$248K Buy
+1,589
New +$239K 0.08% 186

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Chapin Davis's AZN Position: Q2 2026 in Review

Chapin Davis reduced its AstraZeneca (AZN) stake by 26% in Q2 2026, selling an estimated $89.7K and leaving 1,357 shares worth $257K. The position accounts for 0.05% of the portfolio, ranked #210.

Chapin Davis first reported a position in AZN in Q2 2024 and has held it in 9 quarters since. The position peaked at $362K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Chapin Davis held 1,357 shares of AstraZeneca worth $257K as of Q2 2026.
  • Chapin Davis sold 477 AstraZeneca shares in Q2 2026, an estimated $89.7K.
  • AstraZeneca made up 0.05% of Chapin Davis's portfolio in Q2 2026, its #210 holding.
  • Chapin Davis first reported a position in AstraZeneca in Q2 2024 and has held it in 9 quarters since.
  • Chapin Davis's AstraZeneca position peaked at $362K in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Chapin Davis's 13F filing for Q2 2026, filed 7 Jul 2026.